Live Breaking News & Updates on ஶ்லெஸிந்‌ஜர் நூலகம் இல் ராட்க்ளிஃப் நிறுவனம்

Regulus Announces Addition to Board of Directors
News provided by
Share this article
LA JOLLA, Calif., Jan. 27, 2021 /PRNewswire/
 Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced Alice S. Huang, Ph.D. has been appointed to the Company s board of directors. Concurrently with her appointment to the Board, Dr. Huang was appointed to serve on the Compensation Committee.
We are pleased to add Dr. Huang to the Regulus board.  We believe her extensive scientific background will be of benefit to helping direct the Company s drug discovery and development programs, said Stelios Papadopoulos, Ph.D., Chairman of the Board of Directors of Regulus.  ....

United States , University Of Massachusetts , Stelios Papadopoulos , Alices Huang , Johns Hopkins University , National Foundation For Infectious Diseases , National Cancer Institute , Health Effects Institute , Compensation Committee , American Association For The Advancement Of Science , American Academy Of Microbiology , Food Drug Administration , Us Army Medical Research Development , Schlesinger Library At Radcliffe Institute , Regulus Therapeutics Inc , American Association Of Women , California Institute Of Technology , Molecular Genetics At Harvard Medical School , Rockefeller Foundation , Professor Of Biology At New York University , Regulus Therapeutics , Senior Faculty Associate , Biological Engineering , California Institute , New York University , Molecular Genetics ,